Obrigado a todos os que passaram pelo Centro #CiênciaViva. Foi um prazer receber-vos e partilhar um pouco do nosso trabalho convosco!
Thank you to everyone who stopped by Centro Ciência Viva. It was a pleasure to welcome you and share a bit of our work with you!
#SCT2025 #ICArEHB
🔬Mañana último evento de la #SCT2025 en el #IIBM
🔥Nuevo taller científico para la #SemandelaCiencia organizado por nuestros investigadores JUNIOR: Rodrigo Landauro, Javier Ruiz y Celia González 👏👏👏
Nos acompañan 30 alumn@s de EPSUM FP Laboratorio Clínico y Biomédico: ¡¡se sentirán verdaderos 👩🔬👨🔬!!
¡Y este año estrenamos un nuevo taller! 👇
🚀 Rodrigo Landauro, Javier Ruiz y Celia González presentarán un nuevo taller de biología celular 👏
Una actividad pensada para que estudiantes descubran la ciencia de cerca y experimenten en el laboratorio. 💡 🔍
¡Bienvenidos a la #SCT2025! 🙌
Jara Pérez, investigadora del
@ictancsic.bsky.social, presenta en el @ccsciencia.bsky.social su taller de cata de galletas para estimular el consumo de fibra y que entendamos mejor qué comemos para que no nos engañen. El taller forma parte de la #ConexiónTrigo y estará en la #SCT2025 en el ICTAN
SCT 2025 108 km road cycling today at Imatra - Lappeenranta with appr. 1000 other cyclists. #SCT2025
📣 #MSKBiostats was well represented at the 46th Society for Clinical Trials Annual Meeting!
⭐️ We are proud of our dedicated team members, whose commitment to #ClinicalResearch and innovation is making a global impact on the international stage
#SCT2025
A great talk at #SCT2025 by James Salsbury entitled
Assurance methods for designing a survival trial with delayed treatment effects
Attending an excellent talk by Nikki Totton at #SCT2025 entitled
Using benefit risk methods to adjust the non-inferiority margin based on treatment benefits
@anniestats.bsky.social gave a great talk on decentralised trials. Main message from PhD review work is there isn't a one size fits all approach. Trial design may need to be contextually determined and responsive to population needs #SCT2025
@liamhbishophealth.bsky.social kicks off his talk at #SCT2025 by thanking the Society for continuing to create space for raising EDI issues in clinical trials through recognition across sessions and committees. And gives a great talk on building trust through community focussed workshops and videos.
Using imp sci to consider how actionable regulatory guidance is for diversity in clinical trials. Rebecca Metcalfe highlights that more work is needed to make system-level changes to where and how trials are conducted. Building trusted relationships & enforcing guidance are key next steps #SCT2025
When your colleague borrows the registration sign for the group photo. 📸
So you get creative 😅
Happy #internationalclinicaltrialsday !
Really enjoying #SCT2025 so far.
If you want more trials methods research post #SCT2025 please do come to #ICTMC2026 in Birmingham UK 14-17 September. More here ictmc.org
Adwoa Parker walking us through the update of the Cochrane review on interventions to improve recruitment. 7 years & >50 new studies doesn't tell us much more with high certainty. Suggests trialists think carefully about using interventions with no effect (bottom 3 in pic) #SCT2025
Founders Lecture #SCT2025 on DMCs - Thomas Fleming flags the @nihr.bsky.social funded DAMOCLES study that developed a charter for DMCs to support them to do their jobs well. Full paper here www.thelancet.com/journals/lan...
👏 Big thanks to everyone who joined us at Invited Session 5 yesterday on The Modern Clinical Trial!
📸 Pictured: Dr. Colin Begg from #MSKBiostats discussing "Threats to the Validity of Clinical Trials & the Use of External Controls"
❗ More to come at #SCT2025! Stay tuned!
My highlight from #SCT2025 day 1 was Mollie Paynes talk on her PhD research on dose-response methodology in complex intervention trials. It's always great to hear a statistics talk that non-statisticians can also follow. Perfectly pitched. More on Mollies work here github.com/molliejpayne...
Late breaking session at #SCT2025 on the impact of recent US govt actions. So important for us to come together as a trials community to collectively support the research endeavour and our US colleagues. Flags an opinion piece in @nytimes.com today that encourages us to 'get mad in public'
In 2023, over 7,600 U.S. interventional trials were launched—but most remain small, regardless of sponsor. New #SCT2025 research—featuring contributions from #CTTI’s Sara Bristol Calvert—breaks down trial size, focus, and funder differences. Don’t miss it tomorrow!
At #SCT2025, DCRI’s Chris Lindsell will be discussing the establishment of the DCRI-led UNICORN coordinating center. Two roundtable sessions will also be DCC-focused and led by UNICORN members. Learn more about the UNICORN DCC and how to get involved: unicorn-dcc.org
There is a need for trials methodology research for trials designed & delivered in the global south. Sangeetha Paramasivan flags article on need for this work in RCTs in India & talks through adaptation of quintet recruitment intervention in this setting #SCT2025 www.thelancet.com/journals/lan...
Come meet CITI Program at the SCT 46th Annual Meeting! Chat with our team to learn more about our clinical research training and other course offerings. Find us at booth # 1!
#SCT2025 #ClinicalTrials #ClinicalResearch
Arun Sanyal giving the Curtis Meinert Keynote @ #SCT2025 talks us through the use of Desirability of Outcome Ranking (DOOR) in liver trials. Makes a suggestion for pan-specialty #CoreOutcomeSets to facilitate DOOR integration in evidence synthesis for intersecting clinical contexts.
We are also presenting the first results of SPRUCE today, a study which investigated electronic vs paper questionnaire completion by our trial participants #SCT2025 #ClinicalTrials
Presenting a #patientreportedoutcomes workshop at Society for Clinical Trials 46th Annual Meeting! #SCT2025 #clinicaltrials #PROs @christinayap.bsky.social
It’s a busy conference weekend! Today is the start of:
• #HeartFailure2025 in Belgrade
• #SCT2025 in Vancouver
• #ATS2025 in San Francisco
Check the images below for the rundown on DCRI member sessions.
If your heading to the 46th Annual Society for Clinical Trials Meeting (18th May–21st May) don't miss @anniestats.bsky.social & Consuelo from @imperialctu.bsky.social @statsci.bsky.social who will be presenting on these exciting topics! #SCT2025 #ClinicalTrials
📣At #SCT2025, I-Hsin Lin from #MSKBiostats will join SCT leadership at the Business Session (5/20 at 11:45AM PT) to share SCT Comms Committee updates, including:
✅New LinkedIn page
✅Revamped newsletter
✅Social Media Ambassadors
✅Cross-promotion across SCT & global partners
Don't miss this session!
📢 Excited for the 46th Annual Society for Clinical Trials Meeting (5/18–5/21)!
Alexia Iasonos from #MSKBiostats will present “The Promise & Pitfalls of Artificial Intelligence and Machine Learning (AIML) in Clinical Trials” Tues 5/20, 1–2:30 PM PT.
#SCT2025 #ClinicalTrials
